Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678193 · ClinicalTrials.gov registry record
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
A clinical trial of Covid19, sponsored by Aventyn.
- Recruiting
- Registry status
- 27,000
- Enrollment target
- 3
- Study locations
NCT04678193 is a study of Covid19 that is actively recruiting participants, run by Aventyn. The registered enrollment target is 27,000 participants, above the 2,415-participant average among 94 other Covid19 trials with a reported enrollment target (1018% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT04678193, a study of Covid19, is actively recruiting participants, sponsored by Aventyn.
- RECRUITING
- Registry status
- 27,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental health assessments with digital technology using wearables and mobile app tools. Researchers aim to study in Phase 1, epidemiological variations in COVID-19 presentation in both PCR positive and negative subjects in the registry. Assessment of variables, predictive modeling of variables that impact severity of COVID-19 positive and negative subjects and assessment of predictors for post COVID-19 complications. In Phase 2, 2700 subjects with COVID-19 positive test will be studied in the intervention group comparing ECL-19 vs placebo with primary end point of hospital admission assessment. Treatment strategy for PCR positive COVID-19 subjects in the registry who are in Stage I of the disease process with ECL-19 drug compared to placebo in reducing hospital admissions
Conditions Studied
Interventions
- DRUG Coromec Registry with ECL-19
Study Locations (3)
Other
- Multiple Locations - Bangalore
- Multiple Locations - Stockholm
Arizona
- Multiple Locations - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,000 participants |
| Start Date | 2020-12-24 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04678193
The ClinicalTrials.gov registry entry for NCT04678193 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 27,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,415-participant average among 94 other Covid19 trials with a reported enrollment target (1018% higher). The listed sponsor is Aventyn, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Coromec Registry with ECL-19 is the first listed.
NCT04678193 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Arizona.
Frequently Asked Questions
What is clinical trial NCT04678193 about?
NCT04678193 is a clinical study titled "COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy". Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental health assessments with digital technology using wearables and mobile app tools. Researchers aim to stud...
What is the current status of trial NCT04678193?
This trial is currently recruiting. The enrollment target is 27,000 participants. The study started on 2020-12-24. Estimated completion is 2026-06-30.
What conditions does trial NCT04678193 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04678193?
The interventions under investigation include: Coromec Registry with ECL-19 (DRUG).
Who is sponsoring clinical trial NCT04678193?
This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04678193 being conducted?
This trial has 3 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.